SynthesisBMC cancer2025

Combination of immunotherapy and chemotherapy as first-line treatment for advanced or recurrent endometrial cancer: a meta-analysis of phase 3 trials.

Rongxia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.